This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a dihydroindenamine core with fluorine substituents, makes it a valuable intermediate for designing molecules with potential biological activity. It is often explored in the development of central nervous system (CNS) targeting drugs, such as antidepressants or anxiolytics, due to its ability to interact with neurotransmitter systems. Additionally, its fluorine atoms enhance metabolic stability and bioavailability, making it a useful scaffold in medicinal chemistry. Researchers also investigate its potential in creating compounds for treating inflammatory or neurodegenerative disorders.